These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34887219)

  • 21. Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysis.
    Du Y; Wang S; Chen Z; Sun S; Zhao Z; Li X
    Curr Pharm Des; 2018; 24(34):4044-4050. PubMed ID: 30569848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerivastatin, genetic variants, and the risk of rhabdomyolysis.
    Marciante KD; Durda JP; Heckbert SR; Lumley T; Rice K; McKnight B; Totah RA; Tamraz B; Kroetz DL; Fukushima H; Kaspera R; Bis JC; Glazer NL; Li G; Austin TR; Taylor KD; Rotter JI; Jaquish CE; Kwok PY; Tracy RP; Psaty BM
    Pharmacogenet Genomics; 2011 May; 21(5):280-8. PubMed ID: 21386754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke.
    Zhang L; Lv H; Zhang Q; Wang D; Kang X; Zhang G; Li X
    Curr Pharm Des; 2019; 25(14):1663-1670. PubMed ID: 31298164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care.
    DeGorter MK; Tirona RG; Schwarz UI; Choi YH; Dresser GK; Suskin N; Myers K; Zou G; Iwuchukwu O; Wei WQ; Wilke RA; Hegele RA; Kim RB
    Circ Cardiovasc Genet; 2013 Aug; 6(4):400-8. PubMed ID: 23876492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of major
    Alrajeh K; AlAzzeh O; Roman Y
    Pharmacogenomics; 2023 May; 24(7):381-398. PubMed ID: 37222158
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Türkmen D; Bowden J; Masoli JAH; Melzer D; Pilling LC
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
    Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
    Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
    Voora D; Shah SH; Spasojevic I; Ali S; Reed CR; Salisbury BA; Ginsburg GS
    J Am Coll Cardiol; 2009 Oct; 54(17):1609-16. PubMed ID: 19833260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of
    Mladenovska K; Grapci AD; Vavlukis M; Kapedanovska A; Eftimov A; Geshkovska NM; Nebija D; Dimovski AJ
    Pharmazie; 2017 May; 72(5):288-295. PubMed ID: 29441875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals.
    Prado Y; Saavedra N; Zambrano T; Lagos J; Rosales A; Salazar LA
    Int J Mol Sci; 2015 Aug; 16(9):20609-19. PubMed ID: 26334272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.
    Santos PC; Soares RA; Nascimento RM; Machado-Coelho GL; Mill JG; Krieger JE; Pereira AC
    BMC Med Genet; 2011 Oct; 12():136. PubMed ID: 21992719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care.
    Voora D; Baye J; McDermaid A; Narayana Gowda S; Wilke RA; Nicole Myrmoe A; Hajek C; Larson EA
    Clin Pharmacol Ther; 2022 May; 111(5):1075-1083. PubMed ID: 35034348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
    Khine H; Yuet WC; Adams-Huet B; Ahmad Z
    Am Heart J; 2016 Sep; 179():1-9. PubMed ID: 27595674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N
    Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic frequencies of polymorphism c.521T>C (rs4149056) favor preemptive
    Németh S; Kriegshäuser G; Hayrapetyan H; Oberkanins C; Sarkisian T
    Drug Metab Pers Ther; 2024 Sep; 39(3):159-161. PubMed ID: 38997114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
    Nissen SE; Dent-Acosta RE; Rosenson RS; Stroes E; Sattar N; Preiss D; Mancini GB; Ballantyne CM; Catapano A; Gouni-Berthold I; Stein EA; Xue A; Wasserman SM; Scott R; Thompson PD;
    Clin Cardiol; 2016 Mar; 39(3):137-44. PubMed ID: 26946077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
    Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
    Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of
    Brunette CA; Vassy JL
    Pharmacogenomics; 2021 Jul; 22(11):649-656. PubMed ID: 34196599
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic and Clinical Factors Are Associated With Statin-Related Myotoxicity of Moderate Severity: A Case-Control Study.
    Bakar NS; Neely D; Avery P; Brown C; Daly AK; Kamali F
    Clin Pharmacol Ther; 2018 Jul; 104(1):178-187. PubMed ID: 28940218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of statin-induced myopathy.
    Ghatak A; Faheem O; Thompson PD
    Atherosclerosis; 2010 Jun; 210(2):337-43. PubMed ID: 20042189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.